Long non-coding RNA profiling of hypertrophic cardiomyopathy in mice

Graham A Branscom1, Michael P Morley2, Jonathan J Herrera3

  • 1Cardiology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. graham.branscom@icahn.mssm.edu.

Scientific Data
|April 6, 2026
PubMed

Insights

Long non-coding RNAs (lncRNAs) are key regulators in cellular processes. This study identifies differentially expressed lncRNAs in a mouse model of hypertrophic cardiomyopathy (HCM), offering insights into disease mechanisms.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Long non-coding RNAs (lncRNAs) are crucial regulators of gene expression.
  • Hypertrophic cardiomyopathy (HCM) is a prevalent inherited heart condition.
  • The role of lncRNAs in HCM pathophysiology is currently unknown.

Purpose of the Study:

  • To investigate the role of lncRNAs in the development of hypertrophic cardiomyopathy.
  • To identify differentially expressed lncRNAs in a mouse model of HCM.
  • To provide a resource for studying lncRNA function in human HCM.

Main Methods:

  • RNA sequencing (RNA-Seq) was performed on left ventricle samples from transgenic HCM TNNT2 ∆160 mice and non-transgenic controls.
  • Differential expression analysis was conducted to identify dysregulated lncRNAs.
  • Mouse lncRNA genes with human orthologs were identified.

Main Results:

  • A dataset of differentially expressed lncRNAs was generated from HCM mouse models.
  • Specific lncRNAs were found to be dysregulated in the context of HCM.
  • A list of mouse lncRNAs with human orthologs was compiled.

Conclusions:

  • lncRNAs are likely involved in the pathophysiology of hypertrophic cardiomyopathy.
  • This study provides a valuable dataset for further research into lncRNA function in HCM.
  • The identified human orthologs facilitate translational studies for human HCM.